Plain-English translation of NCT07535268 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is collecting real-world data on pulsed field ablation (PFA), a newer catheter-based procedure that treats atrial fibrillation—a condition where your heart beats irregularly. Researchers want to understand how well and safely this treatment works specifically in Black, Hispanic, Asian, Native American, and other minority patients, who have historically been left out of heart rhythm research.
Minority patients with irregular heartbeat tend to have worse outcomes and receive ablation treatment less often than white patients, but there is very little data about why this happens or how well the newer treatment works in these groups. This study aims to fill that gap and improve care for underrepresented communities.
You likely qualify if…
You likely don't qualify if…
You would undergo pulsed field ablation, a catheter-based procedure to treat your irregular heartbeat, as part of your standard medical care. After the procedure, you would return for follow-up visits and evaluations over the course of one year so researchers can track how well the treatment worked and whether you experience any side effects. Throughout the study, you'll share information about your health outcomes with the research team.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
United States
Sponsor
Vivek Reddy
Collaborators
Boston Scientific Corporation
Enrollment target
~275 participants
Started
March 2026
Primary completion
March 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Devin Chamberlain
Icahn School of Medicine at Mount Sinai
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.